Clinical Trial Update: Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry reports results from a Phase 2 study evaluating different regimens of pegylated interferon in combination with lamivudine for chro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Epivir (Lamivudine)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED